Commentary
Commentaries are short perspectives by experts on AJKD articles or nephrology news.
Orhan Efe @OrhanEfe_ Dr. Orhan Efe is a Nephrologist at Massachusetts General Hospital in Boston, MA. Dr. Efe was an AJKD Editorial Intern from 2021-2022. He is passionate
[...]Ana Cecilia Farfan Ruiz @AnaCeciliaFarf1 Dr. Ana Cecilia Farfan Ruiz was an AJKD Editorial Intern from 2021-2022. She is currently a renal transplant fellow at the Mayo
[...]Raphael Rosen @RaphyRosen Dr. Raphael Rosen was an AJKD Editorial Intern from 2021-2022. A recent graduate of nephrology fellowship at Columbia University, he is a
[...]Peritoneal dialysis–associated peritonitis contributes significantly to morbidity and mortality among peritoneal dialysis (PD) patients and to the utilization of health
[...]Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are an emerging class of medications that have become increasingly popular in medication regimens for diabetic patients
[...]Chronic kidney disease (CKD) is a significant public health issue that affects more than 37 million individuals in the United States. Due to its progressive nature and the
[...]Focal segmental glomerulosclerosis (FSGS) is a histologically-defined lesion that results from many etiologies such as drugs, infections, and genetic mutations. It can also
[...]It took a strong woman to pioneer research in the field of women’s health and certainly Dr Susan Hou was one. During her career, she worked tirelessly to help us understand
[...]This is a 2 part blog post by #NephJC cofounder, hypertension guru and longtime AJKD contributor Swapnil Hiremath. In Part 1, he outlined the quandaries of blood pressure
[...]This is a 2-part blog post by #NephJC cofounder, hypertension guru, and longtime AJKD contributor Swapnil Hiremath. In Part 1, he outlines the quandaries of blood pressure
[...]
